Recurrent differentiated thyroid cancer

Endocrine Practice

Volumn 18, Issue 4, 2012, Pages 600-603

  Shaha, Ashok R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; RADIOACTIVE IODINE; THYROGLOBULIN;

CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; DIFFERENTIATED THYROID CANCER; DISTANT METASTASIS; ECHOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GENE MUTATION; GROUPS BY AGE; HIGH RISK PATIENT; HISTOLOGY; HUMAN; HYPOPARATHYROIDISM; INCIDENCE; LARYNX; LYMPH NODE METASTASIS; NERVOUS SYSTEM INJURY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; RECURRENCE RISK; RECURRENT CANCER; RECURRENT LARYNGEAL NERVE; RECURRENT LARYNGEAL NERVE INJURY; RESPIRATION CONTROL; REVIEW; RISK ASSESSMENT; TRACHEA;

EID: 84864664044     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP12047.CO     Document Type: Review

References (16)

1. Shaha A. Treatment of thyroid cancer based on risk groups. J Surg Oncol. 2006;94:683-691.
2. Robbins RJ, Wan Q, Grewal RK, et al. Real-time prog-nosis for metastatic thyroid carcinoma based on 2-18F-fuoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2006;91:498-505.
3. Shah JP, Loree TR, Dharker D, Strong EW, Begg C, Vlamis V. Prognostic factors in differentiated carcinoma of the thyroid gland. Am J Surg. 1992;164:658-661.
4. Aygun N. Imaging of recurrent thyroid cancer. Otolaryngol Clin North Am. 2008;41:1095-1106, viii.
5. Frilling A, Görges R, Tecklenborg K, et al. Value of pre-operative diagnostic modalities in patients with recurrent thyroid carcinoma. Surgery. 2000;128:1067-1074.
6. Iyer NG, Shaha AR. Management of thyroid nodules and surgery for differentiated thyroid cancer. Clin Oncol (R Coll Radiol). 2010;22:405-412.
7. Cooper DS, Doherty GM, Haugen BR, et al (American Thyroid Association ATA Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer).
8. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differ-entiated thyroid cancer published corrections appear in Thyroid. 2010;20:674-675 and Thyroid. 2010;20:942. Thyroid. 2009;19:1167-1214
9. Patel KN, Shaha AR. Locally advanced thyroid cancer. Curr Opin Otolaryngol Head Neck Surg. 2005;13:112-116.
10. Price DL, Wong RJ, Randolph GW. Invasive thy-roid cancer: management of the trachea and esophagus. Otolaryngol Clin North Am. 2008;41:1155-1168, ix-x.
11. Tuttle RM, Leboeuf R, Shaha AR. Medical management of thyroid cancer: a risk adapted approach. J Surg Oncol. 2008;97:712-716.
12. Rosenbluth BD, Serrano V, Happersett L, et al. Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer. Int J Radiat Oncol Biol Phys. 2005;63:1419-1426.
13. Terezakis SA, Lee KS, Ghossein RA, et al. Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2009;73:795-801.
14. Grillo HC, Suen HC, Mathisen DJ, Wain JC. Resectional management of thyroid carcinoma invading the airway Ann Thorac Surg. 1992;54:3-9.
15. Al-Saif O, Farrar WB, Bloomston M, Porter K, Ringel MD, Kloos RT. Long-term effcacy of lymph node reop-eration for persistent papillary thyroid cancer. J Clin Endocrinol Metab. 2010;95:2187-2194.
16. Gopalakrishna Iyer N, Shaha AR. Complications of thy-roid surgery: prevention and management. Minerva Chir. 2010;65:71-82.